Research groups at the Department of Neurology, Faculty of Medicine, University of Debrecen

Department of Neurology consists of two parts: Department of Neurology as a part of the Faculty of Medicine and Department of Neurology as a part of the Clinical Centre. Although all medical doctors (MD) in the department teach students, do clinical work, and do research work, the MDs’ task in faculty position is mainly teaching and doing research work, while the MDs’ task in clinical position is mainly doing clinical work. MDs in clinical position are placed to faculty position if they do research work and fulfill some scientific criteria (doing research work, supervising students’ diplom work, publishing articles, etc). MDs at faculty position supervise the scientific work of PhD students, who are usually at clinical position and started their scientific work. At the Department of Neurology, Faculty of Medicine, University of Debrecen 3 research groups were formed. The table below show the members of the different research groups at the Department of Neurology, Faculty of Medicine, University of Debrecen.
 

Introduction of the research groups

1. Cerebrovascular and Neurodegenerative Research Group

The Stroke Unit of the Department of Neurology was founded in 1969 by Prof. László Molnár. It was the second stroke unit in Europe. Since 1969, the research teams deal with two main aspects of vascular diseases: investigations of stroke risks and acute stroke patients and clinicopathological comparisons. 

During the last decades the following results have been achieved:
A1. A new method was developed for regional distribution of blood content in ischemic brain tissue.
A2. Human, whole-brain autoradiography and a method for investigating the ischemic penumbra were established in Debrecen. The Debrecen Stroke databank (8000 patients) has been also created.
A3. The accuracy of neurosonological methods for diagnosing  subclinical vascular wall lesions have been validated with clinicopathological comparisons.
A4. Results on stroke-risk and stroke patients
A4.1. A new neurosonological method was developed for simultaneous  testing of cardiac and cerebraral hemodynamics.
A4.2. The impairment of cerebral hemodynamics is present in stroke risk patients (hypertension, diabetes,  migraine)  before the development of clinical symptoms.
A4.3. The non-treated hypertension (the most important stroke risk factor) alone and in combination with hyperlipidemia worsens not only the carotid intima-media-thickness and arterial stiffness, but also the cognition. Both vessel wall properties and cognitive test improve after antihypertensive therapy.  
A4.4. The hemostasis and the outcome after thrombolysis have been also investigated.Among others PAI-1 5G/5G genotype,  Willebrand Factor and low factor XIII levels predict unfavorable outcome in stroke patients treated with intravenous thrombolysis.
A5. Neuropathological studies
Dr. Hortobágyi is a neuropathologist and works in the research group as a part-time employee. He studies brain tissues from patients died after ischemic stroke, or who suffered dementia during his/her life. He collaborates with numerous other research groups from abroad.
A6. Investigation of demyelinating CNS diseases

Dr. Csépány contributes significantly to the work of this research team. She performs studies in multiple sclerosis and investigates risks of MS and MS relapses, outcomes of MS and neuromyelitis optica, as well as the diagnostic criteria and therapeutic effects of immuntherapy and immunmodulating agents. She also contributed to the development of differential diagnostic criteria of MS and neuromyelitis optica. She is a member of The Scientific Panel on Multiple sclerosis, which is dedicated to coordinate research and treatment guidelines for demyelinating diseases.

László Csiba  is the leader of the group, who has 511 publications with 10 348 independent citations. His impact factor:464.1. IF of articles with first or last authorship is 134.988
Functions of Professor Csiba in European scientific societies: former president of the European Stroke Organisation’s Board of Directors, board member of the European Master Course on Stroke and World Stroke Academy, co-author of the 2008 ischemic and 2014 hemorrhagic Stroke European Guideline. Former president of the European Society of Neurosonology and Cerebral Hemodynamics (2009-13). He is honorary member of the Austrian Stroke Society and a visiting professor at the Israel Association of Neurology and universities of Belgrade, Novi  Sad and Cluj. At present, he is the president of Hungarian Neurological Society.

2. Clinical Neurophysiology, Epilepsy and Epidemiology Research Group

This research group focuses on epilepsy research, clinical neurophysiology investigations, but examines also the epidemiology of stroke and epilepsy. The main results af the research group are summarized below.

B1. Outcome of antiepileptic drug treatment of 1282 patients with epilepsy
In a logistic regression model, other CNS-related drugs and the number of prescribed antiepileptic drugs have had a significant influence on the desired outcome of seizure freedom. Comparing the Proportional Reporting Ratio (PRR) and 95% CI of older and newer antiepileptic drugs (AEDs), no significant superiority of newer AEDs was detected. The careful drug selection for epileptic patients must be highlighted in order to improve the outcome, reduce ADRs.

B2. Correlation between prescribed daily dose (PDD), seizure freedom and defined daily dose (DDD) in antiepileptic drug treatment
No significant unfavourable impact of the lower ratio of PDD/DDD on the outcome of achieving seizure freedom has been confirmed. Gender, age, type of seizure, seizure freedom and the number of AEDs have a significant impact on the 75% cut off value of DDD. References for monotherapy DDD values are needed, in order to help with decision making in health care using appropriate calculations.

B3. Status epilepticus (SE)
In everyday practice real-life data are essential. The worst outcome of SE was linked to advanced age, aetiology, new onset, non-convulsive and focal status epilepticus. The administration of newer type AEDs in the SE treatment may have an impact on the prescription pattern after discharge, however older type AEDs are a reasonable choice to achieve seizure freedom after SE. Seizure freedom was significantly higher among patients taking levetiracetam, carbamazepine and valproate.

B4. Clinical neurophysiological examination in evaluating outcome in brain haemorrhage
Alteration of the EEG and TMS parameters anticipated the change in the clinical status. The TMS amplitudes had a better prognostic value than the latencies. Fourteen-days TMS findings showed progression in most of the patients, and deterioration was severe in those who died. The measured blood volume on the first CT was significantly associated with the 3-months-TMS findings. With EEG bilateral cortical dysfunction and epileptiform discharges were detected in 30% and 17% respectively of the patients. In conclusion, with EEG and TMS examinations early prognosis of functional outcome could be estimated. For bilateral functional disturbance in many patients diaschisis effect could be responsible.

B5. EMG, ENG, Single-fiber EMG (SFEMG) and blink reflex examinations in amyotrophic lateral sclerosis (ALS).
Correlation of the severity of symptoms and the findings of electromyography, electroneurography, blink reflex in ALS and parameters estimating prognosis of ALS with repeated examinations were investigated. Despite the typical clinical symptoms only 2/3 of the patients were referred within 6 months for examination. SFEMG was done to measure fiber density and jitter. Even in patients referred early and the symptoms were only mild and localized, the neurophysiological findings were already severe. Fasciculation and fibrillation in clinically not involved muscles are early characteristic signs in ALS. The blink reflex examinations revealed loss of lower brainstem interneurons connectivity. In conclusion, clinical neurophysiological examinations are important not only in diagnostics, but by following the progression too.

B6. Investigation of polyneuropathies and myasthenia gravis
In addition to the research topics mentioned above, Dr. Boczán investigates the genetic background of herediter polyneuropathies, analyses the immuntherapy of refractory myasthenia gravis, and she is also involved in the investigation of the renin-angiotensin system in cardiovascular diseases.

B7. Investigation of stroke epidemiology
The research group observed that repeated rtPA treatment might be safe and effective in patients who had mild or moderate residual symptoms after the index stroke. Our department provides data regularly to the SITS-EAST thrombolysis registry and participates in data evaluation. In this collaborative work high probability of good outcome was shown in acute ischemic stroke patients treated by intravenous thrombolysis. Safety and efficacy of intravenous thrombolysis was found in cases of in-hospital-stroke.

Professor Fekete is the leader of this research group. He is a full professor of neurology with huge experience in clinical neurophysiology and epilepsy research. His IF is 136, he published 194 articles, his citation number is 905. In addition to clinical neurophysiology, senior researchers in this team are experienced EEG, ENG/EMG and sleep medicine specialists. Moreover, Dr. Boczán deals with neurogenetics; at present she has been the president of the Hungarian Society of Clinical Neurogenetics.

3. Neurovascular Research Group

Functional Transcranial Doppler Laboratory was established in 2004 in Debrecen, where the Neurovascular Research Group was formed in the same year. They were one of the first in Hungary to examine the neuronal activity evoked regional flow response, i.e. neurovascular coupling in humans with stroke risk factors and under different vasoactive effects. The research team focused on investigating the neurovascular coupling and cerebral circulation, as well as the vessel morphology. The main results of the research group are summarized below.

C1) Smoking as a stroke risk factor caused long-term disturbance of neurovascular coupling.
C2) Alcohol, also as a stroke risk factor, inhibited the cerebral autoregulation during orthostatic stress, had influence on the neurovascular coupling, and through these mechanisms it might contribute to the increased risk of stroke and syncope. Alcohol consumption was shown to mask the symptoms of vertebrobasilar stroke, therefore it may delay the recognition and treatment of stroke.
C3) Non-steroid anti-inflammatory drugs and hypocapnia, as vasoconstrictive factors, significantly inhibited the neurovascular coupling.
C4) The potent vasodilator acetazolamide did not influence significantly the neurovascular coupling.
C5) The conventional stroke risk factors had negative effects on voasodilation of cerebral microvessels, morphology of cerebral vessels, and cognitive functions.
C6) Autoregulation was disturbed in the early phase of multiple sclerosis.
C7) word recognition based on visual stimulus in sighted and tactile stimulus in blind people resulted in similar flow velocity increase in the posterior cerebral arteries and similar occipital cortex activation.

The research group cooperates with several scientific teams at the university, which activity is proved by joint publications. Active collaboration with other european neurosonology centers (e.g. Department of Neurology, University of Giessen) and Israelian researchers are indicated by common publications and book chapters. 

In 2016 the research group played leading role in organizing the Conference of the European Society of Neurosonology and Cerebral Hemodynamics and the World Federation of Neurosonology in Budapest, Hungary. In 2017 a Case-based workshop was organised with participation of the research team at the Congress of the European Academy of Neurology (Amsterdam). The title of this workshop was „Unusual clinical presentations, interesting diagnostic findings and potential therapeutic solutions”.

Dr. Oláh is the leader of this research group. He is a full professor of neurology and the head of the Department of Neurology, Faculty of Medicine, University of Debrecen. His IF is 123.7, his citation number is 1262.

Publication list of the Department of Neurology: https://tudoster.idea.unideb.hu/puli_print/unit/25

The most important publications from the department in the last 5 years

2021

Orbán-Kálmándi, R., Árokszállási, T., Fekete, I., Fekete, K., Héja, M., Tóth, J., Sarkady, F., Csiba, L., Bagoly, Z.: A Modified in vitro Clot Lysis Assay Predicts Outcomes in Non-traumatic Intracerebral Hemorrhage Stroke Patients: the IRONHEART Study.
Front. Neurol. [Epub ahead of print]2021.

Q2 Neurology (2019)
Q2 Neurology (clinical) (2019)
IF: 2.889 (2019)

Balogh, E., Árokszállási, T., Körtefái, K., Nagy, V., Csiba, L., Oláh, L.: Effects of acute alcohol consumption on neuronal activity and cerebral vasomotor response.
Neurol. Sci. [Epub ahead of print]2021.

Q2 Medicine (miscellaneous) (2019)
Q3 Neurology (clinical) (2019)
Q2 Psychiatry and Mental Health (2019)
IF: 2.415 (2019)

Bagoly, Z., Baráth, B., Orbán-Kálmándi, R., Szegedi, I., Kissné Bogáti, R., Sarkady, F., Csiba, L., Katona, É.: Incorporation of [alfa]2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients.
Biomolecules. 11 (3), 1-13, 2021.

Q1 Biochemistry (2019)
Q2 Molecular Biology (2019)
IF: 4.082 (2019)

Árokszállási, T., Héja, M., Bagoly, Z., Kovács, K., Orbán-Kálmándi, R., Sarkady, F., Tóth, J., Fekete, K., Fekete, I., Csiba, L.: Prognostic value of various hemostasis parameters and neurophysiological examinations in spontaneous intracerebral hemorrhage: the IRONHEART study protocol.
Front. Neurol. 12 1-6, 2021.

Q2 Neurology (2019)
Q2 Neurology (clinical) (2019)
IF: 2.889 (2019)

Fülesdi, B., Farkas, S., Gyöngyösi, Z., Siró, P., Bereczki, D., Bacsó, J., Csiba, L.: Correlation between calcium, water contents and ultrasonographic appearance of atherosclerotic lesions of carotid artery lesions.
Transl. Neurosci. 11 (1), 269-276, 2020.

Q3 Neuroscience (miscellaneous) (2019)
IF: 1.373 (2019)

2020

Nagy, M., Aranyi, S., Opposits, G., Papp, T., Lánczi, L., Berényi, E., Vér, C., Csiba, L., Katona, P., Spisák, T., Emri, M.: Effective connectivity differences in motor network during passive movement of paretic and non-paretic ankles in subacute stroke patients.
PeerJ. 8 1-22, 2020.

Q1 Agricultural and Biological Sciences (miscellaneous) (2019)
Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2019)
Q1 Medicine (miscellaneous) (2019)
Q2 Neuroscience (miscellaneous) (2019)
IF: 2.379 (2019)

Hajas, O., Bagoly, Z., Tóth, N., Urbancsek, R., Kiss, A., Kovács, K., Sarkady, F., Nagy, A., Oláh, A., Nagy, L., Clemens, M., Csiba, L., Csanádi, Z.: Intracardiac Fibrinolysis and Endothelium Activation Related to Atrial Fibrillation Ablation with Different Techniques.
Cardiol Res Pract. 2020 1-8, 2020.

Q3 Cardiology and Cardiovascular Medicine (2019)
IF: 1.292 (2019)

Cserép, C., Pósfai, B., Lénárt, N., Fekete, R., László, Z., Lele, Z., Orsolits, B., Molnár, G., Heindl, S., Schwarcz, A., Ujvári, K., Környei, Z., Tóth, K., Szabadits, E., Sperlágh, B., Baranyi, M., Csiba, L., Hortobágyi, T., Maglóczky, Z., Martinecz, B., Szabó, G., Erdélyi, F., Szipőcs, R., Tamkun, M., Gesierich, B., Duering, M., Katona, I., Liesz, A., Tamás, G., Dénes, Á.: Microglia monitor and protect neuronal function via specialized somatic purinergic junctions.
Science. 367 (6477), 528-537, 2020.

D1 History and Philosophy of Science (2019)
D1 Multidisciplinary (2019)
IF: 41.845 (2019)

Laczkóné Majer, R., Adeyi, O., Bagoly, Z., Simon, V., Csiba, L., Kardos, L., Hortobágyi, T., Frecska, E.: Neuropsychiatric symptoms, quality of life and caregivers' burden in dementia.
Open Med. 15 (1), 905-914, 2020.

Q3 Medicine (miscellaneous) (2019)
IF: 1.204 (2019)

Tárkányi, G., Karádi, Z., Szabó, Z., Szegedi, I., Csiba, L., Szapáry, L.: Relationship between leukocyte counts and large vessel occlusion in acute ischemic stroke.
BMC Neurol. 20 (1), 1-8, 2020.

Q1 Medicine (miscellaneous) (2019)
Q2 Neurology (clinical) (2019)

Tárkányi, G., Karádi, Z., Szabó, Z., Szegedi, I., Csiba, L., Szapáry, L.: Relationship between leukocyte counts and large vessel occlusion in acute ischemic stroke.
BMC Neurol. 20 (1), 1-8, 2020.

Q1 Medicine (miscellaneous) (2019)
Q2 Neurology (clinical) (2019)

Bagoly, Z., Hajas, O., Urbancsek, R., Kiss, A., Fiak, E., Sarkady, F., Tóth, N., Orbán-Kálmándi, R., Kovács, K., Nagy, L., Nagy, A., Kappelmayer, J., Csiba, L., Csanádi, Z.: Uninterrupted Dabigatran Administration Provides Greater Inhibition against Intracardiac Activation of Hemostasis as Compared to Vitamin K Antagonists during Cryoballoon Catheter Ablation of Atrial Fibrillation.
J Clin Med. 9 (9), 1-13, 2020.

IF: 3.303 (2019)

2019

Árokszállási, T., Balogh, E., Csiba, L., Fekete, I., Fekete, K., Oláh, L.: Acute alcohol intoxication may cause delay in stroke treatment: case reports.
BMC Neurol. 19 (1), 1-5, 2019.

Q1 Medicine (miscellaneous)
Q2 Neurology (clinical)

Laczkóné Majer, R., Simon, V., Csiba, L., Kardos, L., Frecska, E., Hortobágyi, T.: Behavioural and Psychological Symptoms in Neurocognitive Disorders: specific Patterns in Dementia Subtypes.
Open Med. (Wars). 14 (1), 307-316, 2019.

Q3 Medicine (miscellaneous)
IF: 1.204

Balogh, E., Árokszállási, T., Csiba, L., Oláh, L.: Effect of reading with direct or indirect light on the visually evoked flow response in the posterior cerebral artery.
J. Clin. Ultrasound. 47 (5), 272-277, 2019.

Q3 Radiology, Nuclear Medicine and Imaging
IF: 0.764

Czuriga-Kovács, K., Szekeres, C., Bajkó, Z., Csapó, K., Oláh, L., Magyar, M., Molnár, S., Czuriga, D., Kardos, L., Burainé Bojtor, A., Bereczki, D., Soltész, P., Csiba, L.: Hypertension-induced subclinical vascular and cognitive changes are reversible: an observational cohort study.
J. Clin. Hypertens. 21 (5), 658-667, 2019.

Q2 Cardiology and Cardiovascular Medicine
Q2 Endocrinology, Diabetes and Metabolism
Q2 Internal Medicine
IF: 2.719

Csikai, E., Andrejkovics, M., Balajthy-Hidegh, B., Hofgárt, G., Kardos, L., Diószegi, Á., Rostás, R., Czuriga-Kovács, K., Csongrádi, É., Csiba, L.: Influence of angiotensin-converting enzyme inhibition on reversibility of alterations in arterial wall and cognitive performance associated with early hypertension: a follow-up study.
Medicine (Baltimore). 98 (34), 1-9, 2019.

Q2 Medicine (miscellaneous)
IF: 1.552

Clemens, B., Dömötör, J., Emri, M., Puskás, S., Fekete, I.: Inter-ictal network of focal epilepsy and effects of clinical factors on network activity.
Clin. Neurophysiol. 130 (2), 251-258, 2019.

Q1 Neurology
Q1 Neurology (clinical)
Q1 Physiology (medical)
Q1 Sensory Systems
IF: 3.214

Bagoly, Z., Szegedi, I., Orbán-Kálmándi, R., Tóth, N., Csiba, L.: Markers of Coagulation and Fibrinolysis Predicting the Outcome of Acute Ischemic Stroke Thrombolysis Treatment: a Review of the Literature.
Front. Neurol. 10 1-13, 2019.

Q2 Neurology
Q2 Neurology (clinical)
IF: 2.889

Bencze, J., Szarka, M., Bencs, V., Szabó, R., Smajda, M., Aarsland, D., Hortobágyi, T.: Neuropathological characterization of Lemur tyrosine kinase 2 (LMTK2) in Alzheimer's disease and neocortical Lewy body disease.
Sci. Rep. 9 (1), 1-9, 2019.

D1 Multidisciplinary
IF: 3.998

Szegedi, I., Nagy, A., Székely, E., Czuriga-Kovács, K., Sarkady, F., Lánczi, L., Berényi, E., Csiba, L., Bagoly, Z.: PAI-1 5G/5G genotype is an independent risk of intracranial hemorrhage in post-lysis stroke patients.
Ann. Clin. Trans. Neurol. 6 (11), 2240-2250, 2019.

D1 Neurology (clinical)
Q1 Neuroscience (miscellaneous)
IF: 3.66

Horváth, L., Fekete, I., Molnár, M., Válóczy, R., Márton, S., Fekete, K.: The outcome of status epilepticus and long-term follow-up.
Front. Neurol. 10 (427), 1-8, 2019.

Q2 Neurology
Q2 Neurology (clinical)
IF: 2.889

2018

Székely, E., Czuriga-Kovács, K., Bereczky, Z., Katona, É., Mezei, Z., Nagy, A., Tóth, N., Berényi, E., Muszbek, L., Csiba, L., Bagoly, Z.: Low factor XIII levels after intravenous thrombolysis predict short-term mortality in ischemic stroke patients.
Sci. Rep. 8 (1), 1-9, 2018.

D1 Multidisciplinary
IF: 4.011

2017

Csongrádi, É., Káplár, M., Nagy, B., Koch, C., Juhász, A., Bajnok, L., Varga, Z., Seres, I., Karányi, Z., Magyar, M., Oláh, L., Facskó, A., Kappelmayer, J., Paragh, G.: Adipokines as atherothrombotic risk factors in obese subjects: associations with haemostatic markers and common carotid wall thickness.
Nutr. Metab. Carbiovasc. Dis. 27 (6), 571-580, 2017.

Q1 Cardiology and Cardiovascular Medicine
Q1 Endocrinology, Diabetes and Metabolism
Q1 Medicine (miscellaneous)
Q1 Nutrition and Dietetics
IF: 3.318

Horváth, L., Fekete, K., Márton, S., Fekete, I.: Correlation between prescribed daily dose, seizure freedom and defined daily dose in antiepileptic drug treatment.
Int. J. Clin. Pharm. 37 459-467, 2017.

Q1 Pharmaceutical Science
Q2 Pharmacology
Q2 Pharmacology (medical)
Q1 Pharmacy
Q2 Toxicology
IF: 1.508

Dömötör, J., Clemens, B., Puskás, S., Fekete, I.: Decrease of global current source density predicts successful treatment in absence and juvenile myoclonic epilepsies.
Epilepsy Res. 133 1-5, 2017.

Q2 Neurology
Q2 Neurology (clinical)
IF: 2.491

Tóth, N., Csanádi, Z., Hajas, O., Kiss, A., Nagy-Baló, E., Kovács, K., Sarkady, F., Muszbek, L., Bereczky, Z., Csiba, L., Bagoly, Z.: Intracardiac hemostasis and fibrinolysis parameters in patients with atrial fibrillation.
Biomed Res. Int. 2017 (3678017), 1-10, 2017.

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q2 Immunology and Microbiology (miscellaneous)
Q1 Medicine (miscellaneous)
IF: 2.583

Tsivgoulis, G., Katsanos, A., Kadlecova, P., Czlonkowska, A., Kobayashi, A., Brozman, M., Švigelj, V., Csiba, L., Fekete, K., Körv, J., Demarin, V., Vilionskis, A., Jatuzis, D., Krespi, Y., Liantinioti, C., Giannopoulos, S., Mikulík, R.: Intravenous thrombolysis for ischemic stroke in the golden hour: propensity-matched analysis from the SITS-EAST registry.
J. Neurol. 264 (5), 912-920, 2017.

Q1 Neurology
Q1 Neurology (clinical)
IF: 3.783

Tsivgoulis, G., Katsanos, A., Kadlecova, P., Czlonkowska, A., Kobayashi, A., Brozman, M., Švigelj, V., Csiba, L., Fekete, K., Kõrv, J., Demarin, V., Vilionskis, A., Jatuzis, D., Krespi, Y., Karapanayiotides, T., Giannopoulos, S., Mikulík, R.: Intravenous thrombolysis for patients with in-hospital stroke onset: propensity-matched analysis from the Safe Implementation of Treatments in Stroke-East registry.
Eur. J. Neurol. 24 (12), 1493-1498, 2017.

Q1 Neurology
Q1 Neurology (clinical)
IF: 4.621

Kovács, E., Dankó, K., Nagy-Vincze, M., Csiba, L., Boczán, J.: Long-term treatment of refractory myasthenia gravis with subcutaneous immunoglobulin.
Ther. Adv. Neurol. Disord. 9 1-4, 2017.

Q1 Neurology
Q1 Neurology (clinical)
Q1 Pharmacology
IF: 4.75

Hudák, R., Székely, E., Czuriga-Kovács, K., Nagy, A., Hofgárt, G., Berényi, E., Csiba, L., Kappelmayer, J., Bagoly, Z.: Low thrombin generation predicts poor prognosis in ischemic stroke patients after thrombolysis.
PLoS One. 12 (7), 1-13, 2017.

Q1 Agricultural and Biological Sciences (miscellaneous)
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q1 Medicine (miscellaneous)
IF: 2.766

Fekete, K., Márton, S., Csiba, L., Fekete, I.: Outcome of Repeated Thrombolysis in Debrecen Thrombolysis Database.
J. Stroke Cerebrovasc. Dis. 26 (1), 132-138, 2017.

Q2 Cardiology and Cardiovascular Medicine
Q2 Neurology (clinical)
Q2 Rehabilitation
Q2 Surgery
IF: 1.598

Szegedi, I., Szapáry, L., Csanádi, Z., Csiba, L.: Potential biological markers of atrial fibrillation: a chance to prevent cryptogenic stroke.
Biomed Res. Int. 2017 (8153024), 1-10, 2017.

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q2 Immunology and Microbiology (miscellaneous)
Q1 Medicine (miscellaneous)
IF: 2.583

Puskás, S., Kozák, N., Sulina, D., Csiba, L., Magyar, M.: Quantitative EEG in obstructive sleep apnea syndrome: a review of the literature.
Rev. Neurosci. 28 (3), 265-270, 2017.

Q2 Neuroscience (miscellaneous)
IF: 2.59

Malojcic, B., Giannakopoulos, P., Sorond, F., Azevedo, E., Diomedi, M., Oblak, J., Carraro, N., Boban, M., Oláh, L., Schreiber, S., Pavlovic, A., Garami, Z., Bornstein, N., Rosengarten, B.: Ultrasound and dynamic functional imaging in vascular cognitive impairment and Alzheimer's disease.
BMC Med. 15 (1), 1-16, 2017.

D1 Medicine (miscellaneous)
IF: 9.088

2016

Viski, S., Orgovan, D., Szabó, K., Rosengarten, B., Csiba, L., Oláh, L.: Effect of reading on blood flow changes in the posterior cerebral artery in early blind and sighted people: a transcranial Doppler study.
J. Neurol. Sci. 363 132-139, 2016.

Q2 Neurology
Q2 Neurology (clinical)
IF: 2.295

Bagoly, Z., Homoródi, N., Kovács, E., Sarkady, F., Csiba, L., Édes, I., Muszbek, L.: How to test the effect of aspirin and clopidogrel in patients on dual antiplatelet therapy?.
Platelets. 27 (1), 59-65, 2016.

Q2 Hematology
Q2 Medicine (miscellaneous)
IF: 2.465

Clemens, B., Puskás, S., Spisák, T., Lajtos, I., Opposits, G., Besenyei, M., Hollódy, K., Fogarasi, A., Kovács, N., Fekete, I., Emri, M.: Increased resting-state EEG functional connectivity in benign childhood epilepsy with centro-temporal spikes.
Seizure. 35 50-55, 2016.

Q1 Medicine (miscellaneous)
Q2 Neurology
Q2 Neurology (clinical)
IF: 2.448

Czuriga-Kovács, K., Czuriga, D., Csiba, L.: Influence of Hypertension, Alone and in Combination with Other Vascular Risk Factors on Cognition.
CNS Neurol. Disord. Drug Targets. 15 (6), 690-698, 2016.

Q1 Medicine (miscellaneous)
Q2 Neuroscience (miscellaneous)
Q2 Pharmacology
IF: 2.506

Káplár, M., Sweni, S., Kulcsár, J., Cogoi, B., Esze, R., Somodi, S., Papp, M., Oláh, L., Magyar, M., Szabó, K., Czuriga-Kovács, K., Hársfalvi, J., Paragh, G.: Mannose-binding lectin levels and carotid intima-media thickness in type 2 diabetic patients.
J. Diabetes Res. 2016 (8132925), 1-8, 2016.

Q2 Endocrinology
Q2 Endocrinology, Diabetes and Metabolism
IF: 2.717

Horváth, L., Fekete, K., Márton, S., Fekete, I.: Outcome of antiepileptic drug treatment of 1282 patients with epilepsy, their pharmacovigilance reports and concomitant medication on CNS in an East-Hungarian adult database.
J. Neurol. Sci. 369 220-226, 2016.

Q2 Neurology
Q2 Neurology (clinical)
IF: 2.295

Kozák, N., Bereczki, D., Szabó, S.: Predictors of symptomatic vasospasm after subarachnoid hemorrhage: a single center study of 457 consecutive cases.
Turk. Neurosurg. 26 (4), 545-549, 2016.

Q3 Neurology (clinical)
Q3 Surgery
IF: 0.56

Viski, S., Orosz, M., Czuriga-Kovács, K., Magyar, M., Csiba, L., Oláh, L.: The acute effects of alcohol on cerebral hemodynamic changes induced by the head-up tilt test in healthy subjects.
J. Neurol. Sci. 368 113-120, 2016.

Q2 Neurology
Q2 Neurology (clinical)
IF: 2.295

Vér, C., Emri, M., Spisák, T., Berényi, E., Kovács, K., Katona, P., Balkay, L., Menyhárt, L., Kardos, L., Csiba, L.: The Effect of Passive Movement for Paretic Ankle-Foot and Brain Activity in Post-Stroke Patients.
Eur. Neurol. 76 (3-4), 132-142, 2016.

Q3 Neurology
Q2 Neurology (clinical)
IF: 1.697

PhD degree was awarded for the following researchers

2021: Májer Réka Laczkóné
2017: Sándor Viski
2017: Csilla Vér
2017: László Horváth
2016: Norbert Kozák
2015: Katalin Judit Szabó
2015: Katalin Réka Czuriga Kovács
2015: Zsolt Mezei
2014: Klára Fekete
2014: Szabolcs Farkas
2011: Szilvia Puskás
2010: Sándor Molnár